According to new recommendations from cognitive behavior therapy for BED, GLP-1RAs may be cautiously considered in patients with clinical obesity who do not overvalue shape and weight, have no history of anorexia nervosa or bulimia nervosa, and who have already made progress in adopting regular eating patterns and reducing binge-eating episodes
Workplace Incidents : Injuries in construction, manufacturing, and other industries involving dangerous equipment also contribute to TBI cases
An engineered protein tag for multiprotein labeling in living cells
As an injectable medication, it has shown promising effects in controlling hunger and promoting weight loss by targeting areas of the brain that influence food intake
When hundreds of women asked if their "frozen shoulder" was related to menopause, she learned more
Recent registry studies reveal that people taking GLP-1 medications experienced substantially decreased risk of hospitalization due to alcohol use disorder, with semaglutide showing the strongest protection (adjusted hazard ratio 0.64) 25
